Man, cancer and immunity / by 189669 Cochran, Alistair J.

Subjects:

Analyzing T cell responses : how to analyze cellular immune responses against tumor associated antigens / by Nagorsen, Dirk, Marincola, F. M.

Subjects:

Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche by Kelin Gonçalves de Oliveira, Anna Bång-Rudenstam, Sarah Beyer, Axel Boukredine, Hugo Talbot, Valeria Governa, Maria C. Johansson, Ann-Sofie Månsson, Karin Forsberg-Nilsson, Johan Bengzon, Johan Malmström, Charlotte Welinder, Mattias Belting

Subjects: Get full text

Selecting Target Antigens for Cancer Vaccine Development by Luigi Buonaguro, Maria Tagliamonte

Subjects: “…tumor antigens…”
Get full text

Anti-Tumour Promoting Activity of Selected Malaysian Vegetables and Fruits, and Identification of Anti-Tumour Promoting and Antioxidant Compounds from Coleus Tuberosus, Benth (Ubi... by Lim, Yang Mooi

Subjects: Get full text

Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy by Violeta Delgado-Almenta, Jose L. Blaya-Cánovas, Jesús Calahorra, Araceli López-Tejada, Carmen Griñán-Lisón, Sergio Granados-Principal

Subjects: Get full text

Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development by Liguo Ye, Long Wang, Ji’an Yang, Ping Hu, Chunyu Zhang, Shi’ao Tong, Zhennan Liu, Daofeng Tian

Subjects: Get full text

BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens by Maria Virginia Ruiz Cuevas, Marie-Pierre Hardy, Jean-David Larouche, Anca Apavaloaei, Eralda Kina, Krystel Vincent, Patrick Gendron, Jean-Philippe Laverdure, Chantal Durette, Pierre Thibault, Sébastien Lemieux, Claude Perreault, Grégory Ehx

Subjects: Get full text

Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment by Daniela A. Bota, Thomas H. Taylor, David E. Piccioni, Christopher M. Duma, Renato V. LaRocca, Santosh Kesari, Jose A. Carrillo, Mehrdad Abedi, Robert D. Aiken, Frank P. K. Hsu, Xiao-Tang Kong, Candace Hsieh, Peter G. Bota, Gabriel I. Nistor, Hans S. Keirstead, Robert O. Dillman

Subjects: Get full text

Recent Advances in DNA Vaccines against Lung Cancer: A Mini Review by Ting Huang, Li Liu, Zheng Lv, Kelei Zhao, Qiong Yi, Jing Zhang

Subjects: Get full text

LCVM infection generates tumor antigen-specific immunity and inhibits growth of nonviral tumors by Camille Jacqueline, Matthew Dracz, Jia Xue, Robert J. Binder, Jonathan Minden, Olivera Finn

Subjects: “…tumor antigens…”
Get full text

Cancer Vaccines: From the State of the Art to the Most Promising Frontiers in the Treatment of Colorectal Cancer by Eleonora Martinis, Carolina Ricci, Caterina Trevisan, Gaia Tomadini, Silvia Tonon

Subjects: Get full text

Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development by Liguo Ye, Long Wang, Ji’an Yang, Ping Hu, Chunyu Zhang, Shi’ao Tong, Zhennan Liu, Daofeng Tian

Subjects: Get full text

EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER by V. V. Kurilin, E. V. Kulikova, A. V. Sokolov, Yu. A. Kozhevnikov, D. D. Blinova, I. A. Obleukhova, N. M. Starostina, S. V. Sennikov

Subjects: Get full text

Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy by Giorgio Parmiani, Cristina Maccalli, Michele Maio

Subjects: Get full text

Tumors Established in a Defective Immune Environment Reprogram the Oncogenic Signaling Pathways to Escalate Tumor Antigenicity by Chiao-Hsu Ke, Hsin-Yi Wu, Yu-Shan Wang, Wei-Hsiang Huang, Chen-Si Lin

Subjects: Get full text

Therapeutic implications of immunogenic cell death in human cancer by Fabio ePalombo, Chiara eFocaccetti, Vincenzo eBarnaba, Vincenzo eBarnaba

Subjects: Get full text

Therapeutic Cancer Vaccines—Antigen Discovery and Adjuvant Delivery Platforms by Neftali Ortega Alarcon, Maddy Jaramillo, Heidi M. Mansour, Bo Sun

Subjects: Get full text

Bispecific Antibodies for Multiple Myeloma: Recent Advancements and Strategies for Increasing Their Efficacy by Moran Wang, Chaofan Wang, Jun Deng, Huafang Wang, Chunyan Sun, Shanshan Luo, Yu Hu

Subjects: Get full text

Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma by Janet Retseck, Alexis Nasr, Yan Lin, Huang Lin, Prateek Mendiratta, Lisa H. Butterfield, Ahmad A. Tarhini

Subjects: Get full text